Epiruba 50mg Injection
Marketer
Getwell Pharma (I) Pvt Ltd
Salt Composition
Epirubicin (50mg)
Overview Epiruba 50mg Injection
Epiruba 50mg injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; improper usage or overdose can lead to severe adverse reactions. Benefits may take weeks or months to manifest; discontinue only under medical guidance. This medication reduces contraceptive efficacy; reliable contraception is recommended for both partners throughout treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and rash. It can lower blood cell counts, increasing infection risk, which may be life-threatening. Regular blood tests monitoring blood cell counts, kidney, liver, and heart function are essential. Prior to treatment, disclose any liver or heart conditions, and all other medications you're taking, as interactions may compromise efficacy or alter its effects. Report pregnancy or breastfeeding to your physician.
Uses of Epiruba 50mg Injection
Malignant neoplasm
Major Benefits of Epiruba 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Epiruba 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epiruba 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Epiruba 50mg Injection works:
Epiruba 50mg Injection is a chemotherapy agent targeting breast cancer. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication within cancerous breast cells. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, halting cancerous cell proliferation and ultimately inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epiruba 50mg Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Epiruba 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Epiruba 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Epiruba 50mg Injection may result in adverse reactions that can compromise driving capabilities. These reactions may include nausea and vomiting, potentially causing temporary driving impairment.
KidneySAFE IF PRESCRIBED
Epiruba 50mg Injection appears to be safely administered to individuals with kidney impairment. Current evidence indicates dose modification for Epiruba 50mg Injection might be unnecessary in this population. However, physician consultation is recommended. A reduced dosage should be considered for patients exhibiting serum creatinine exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should use Epiruba 50mg Injection cautiously, potentially requiring dosage modification. Consult a physician before use. Epiruba 50mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Epiruba 50mg Injection :
NA
Facts to Know About Epiruba 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline Analog |
| Developing Good Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Cytotoxic alkaloids |
3,018 People bought this recently